Judith V Klimovsky Bellicum Pharmaceuticals, Inc (BLCM) insider trading activity

Judith V Klimovsky is Director of BELLICUM PHARMACEUTICALS, INC. Currently has a direct ownership of 110,098 shares of BLCM, which is worth approximately $0. The most recent transaction as insider was on Jan 03, 2023, when has been sold 60,414 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 110K

0% 3M change

0% 12M change

Total Value Held $0

Judith V Klimovsky Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 03 2023	BUY Exercise of conversion of derivative security	-	60,414 Added 35.43%	110,098 Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	-	35,082 Added 41.39%	49,684 Common Stock
Jan 04 2022	BUY Exercise of conversion of derivative security	-	14,602 Added 50.0%	14,602 Common Stock

Also insider at

TECH

BIO-TECHNE Corp Healthcare

Director

JVK